History
  • No items yet
midpage
Allergan, Inc. v. Revance Therapeutics, Inc.
1:21-cv-01411
| D. Del. | Jun 30, 2025
|
Check Treatment
|
Docket

*1 Case 1:21-cv-01411-RGA-LDH Document 571 Filed 06/30/25 Page 1 of 30 PageID #:

56573 *2 Case 1:21-cv-01411-RGA-LDH Document 571 Filed 06/30/25 Page 2 of 30 PageID #: 56574 *3 Case 1:21-cv-01411-RGA-LDH Document 571 Filed 06/30/25 Page 3 of 30 PageID #: 56575 *4 Case 1:21-cv-01411-RGA-LDH Document 571 Filed 06/30/25 Page 4 of 30 PageID #: 56576 *5 Case 1:21-cv-01411-RGA-LDH Document 571 Filed 06/30/25 Page 5 of 30 PageID #: 56577 *6 Case 1:21-cv-01411-RGA-LDH Document 571 Filed 06/30/25 Page 6 of 30 PageID #: 56578 *7 Case 1:21-cv-01411-RGA-LDH Document 571 Filed 06/30/25 Page 7 of 30 PageID #: 56579 *8 Case 1:21-cv-01411-RGA-LDH Document 571 Filed 06/30/25 Page 8 of 30 PageID #: 56580 *9 Case 1:21-cv-01411-RGA-LDH Document 571 Filed 06/30/25 Page 9 of 30 PageID #: 56581

Case Details

Case Name: Allergan, Inc. v. Revance Therapeutics, Inc.
Court Name: District Court, D. Delaware
Date Published: Jun 30, 2025
Docket Number: 1:21-cv-01411
Court Abbreviation: D. Del.
AI-generated responses must be verified and are not legal advice.
Your Notebook is empty. To add cases, bookmark them from your search, or select Add Cases to extract citations from a PDF or a block of text.